ShardaCare Healthcity has announced the launch of High-Dose-Rate (HDR) Brachytherapy Unit. This technology aims to deliver precision-driven, patient-centric cancer care through cutting-edge innovation ...
UCLA scientists, together with a team of international collaborators, have identified a promising new treatment strategy that ...
A simultaneous or sequential combination of brentuximab vedotin and radiotherapy is feasible and well tolerated in patients ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new research from more than 100 ...